Latigo Biotherapeutics

This is the first study testing a new oral medication called LTG-321 in humans. Researchers will give healthy volunteers increasing doses to check for safety, see how the body processes the drug, and measure its effects on pain tolerance using a cold water test. The goal is to ga…

This is the first study in people for a new drug called LTG-001. Researchers are testing its safety and how it moves through the body in healthy volunteers. The study will give the drug at different doses, both as a pill and through an IV, to see how well it is tolerated.